These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 22122590)

  • 1. Survival and causes of death among HIV-infected patients starting antiretroviral therapy in north-eastern Vietnam.
    Cuong do D; Thorson A; Sönnerborg A; Hoa NP; Chuc NT; Phuc HD; Larsson M
    Scand J Infect Dis; 2012 Mar; 44(3):201-8. PubMed ID: 22122590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.
    Etard JF; Ndiaye I; Thierry-Mieg M; Guèye NF; Guèye PM; Lanièce I; Dieng AB; Diouf A; Laurent C; Mboup S; Sow PS; Delaporte E
    AIDS; 2006 May; 20(8):1181-9. PubMed ID: 16691070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy.
    Paton NI; Sangeetha S; Earnest A; Bellamy R
    HIV Med; 2006 Jul; 7(5):323-30. PubMed ID: 16945078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of HIV-infected patients after starting tuberculosis treatment: a prospective cohort study.
    Maruza M; Albuquerque MF; Braga MC; Barbosa MT; Byington R; Coimbra I; Moura LV; Batista JD; Diniz GT; Miranda-Filho DB; Lacerda HR; Rodrigues LC; Ximenes RA
    Int J Tuberc Lung Dis; 2012 May; 16(5):618-24. PubMed ID: 22410415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with HIV-1 virological failure in an outpatient clinic for HIV-infected people in Haiphong, Vietnam.
    Huong DT; Bannister W; Phong PT; Kirk O; Peters L
    Int J STD AIDS; 2011 Nov; 22(11):659-64. PubMed ID: 22096052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Survival and immune response of rural HIV/AIDS patients after free antiretroviral therapy].
    Ding YY; Jia WQ; Wang JS; Dong SL; Yang QH; Zhou RY; Qu SX; Lu LX; Wei J; Qiao XC; Gao MY; Guo XL; Zhang TJ; Wu ZY; He N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Dec; 29(12):1176-80. PubMed ID: 19173958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.
    Moh R; Danel C; Messou E; Ouassa T; Gabillard D; Anzian A; Abo Y; Salamon R; Bissagnene E; Seyler C; Eholié S; Anglaret X
    AIDS; 2007 Nov; 21(18):2483-91. PubMed ID: 18025885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir.
    Piketty C; Weiss L; Assoumou L; Burgard M; Mélard A; Ragnaud JM; Bentata M; Girard PM; Rouzioux C; Costagliola D;
    J Med Virol; 2010 Nov; 82(11):1819-28. PubMed ID: 20872707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of malnutrition in survival of HIV infected children after initiation of antiretroviral treatment (ART).
    Taye B; Shiferaw S; Enquselassie F
    Ethiop Med J; 2010 Jan; 48(1):1-10. PubMed ID: 20607992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyponatremia, hypochloremia, and hypoalbuminemia predict an increased risk of mortality during the first year of antiretroviral therapy among HIV-infected Zambian and Kenyan women.
    Dao CN; Peters PJ; Kiarie JN; Zulu I; Muiruri P; Ong'ech J; Mutsotso W; Potter D; Njobvu L; Stringer JS; Borkowf CB; Bolu O; Weidle PJ
    AIDS Res Hum Retroviruses; 2011 Nov; 27(11):1149-55. PubMed ID: 21417949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family nutritional support improves survival, immune restoration and adherence in HIV patients receiving ART in developing country.
    Serrano C; Laporte R; Ide M; Nouhou Y; de Truchis P; Rouveix E; Adamou A; Pauly V; Mattei JF; Gastaut JA
    Asia Pac J Clin Nutr; 2010; 19(1):68-75. PubMed ID: 20199989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition.
    Cingolani A; Cozzi Lepri A; Castagna A; Goletti D; De Luca A; Scarpellini P; Fanti I; Antinori A; d'Arminio Monforte A; Girardi E
    Clin Infect Dis; 2012 Mar; 54(6):853-61. PubMed ID: 22157323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia.
    Kassa A; Teka A; Shewaamare A; Jerene D
    Trans R Soc Trop Med Hyg; 2012 Jun; 106(6):363-70. PubMed ID: 22521216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
    Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
    Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.
    Larsen MV; Omland LH; Gerstoft J; Røge BT; Larsen CS; Pedersen G; Obel N; Kronborg G
    Scand J Infect Dis; 2010 Dec; 42(11-12):917-23. PubMed ID: 20840000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virological control during the first 6-18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: a Danish, population-based, 6-year follow-up study.
    Lohse N; Kronborg G; Gerstoft J; Larsen CS; Pedersen G; Pedersen C; Sørensen HT; Obel N
    Clin Infect Dis; 2006 Jan; 42(1):136-44. PubMed ID: 16323104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.